related topics
{disease, patient, cell}
{law, state, case}
{acid, form, water}
{company, market, business}
{rate, high, increase}
{work, book, publish}
{theory, work, human}
{day, year, event}
{city, large, area}
{woman, child, man}
{album, band, music}
{mi², represent, 1st}
{food, make, wine}
{war, force, army}
{school, student, university}

MDMA (3,4-Methylenedioxymethamphetamine) – colloquially known as ecstasy, often abbreviated "E" or "X" – is an entactogenic drug of the phenethylamine and amphetamine class of drugs.

MDMA can induce euphoria, a sense of intimacy with others, and diminished anxiety and depression. Many, particularly in the fields of psychology and cognitive therapy, have suggested MDMA might have therapeutic benefits and facilitate therapy sessions in certain individuals, a practice which it had formally been used for in the past. Clinical trials are now testing the therapeutic potential of MDMA for post-traumatic stress disorder (PTSD) and anxiety associated with terminal cancer.[3][4]

MDMA is criminalized in most countries under a United Nations (U.N.) agreement,[5] and its possession, manufacture, or sale may result in criminal prosecution, although some limited exceptions exist for scientific and medical research. MDMA is one of the most widely used recreational drugs in the world and is taken in a variety of contexts far removed from its roots in psychotherapeutic settings. It is commonly associated with dance parties (or "raves") and electronic dance music.[6]

There have been debates within scientific, health care, and drug policy circles about the risks of MDMA, specifically the possibility of neurotoxic damage to the central nervous system (CNS). Regulatory authorities in several locations around the world have approved scientific studies administering MDMA to humans to examine its therapeutic potential and its effects.[7]

Continuing to study the substance in clinical trials, the Multidisciplinary Association for Psychedelic Studies released the following statement in October 2008, "We found that low doses of MDMA (between 50 and 75 mg) were both psychologically and physiologically safe for all the subjects. Future studies in larger samples and using larger doses are needed in order to further clarify the safety and efficacy of MDMA in the clinical setting in subjects with PTSD."[8]


Full article ▸

related documents
Acne vulgaris
Gene therapy
Obsessive-compulsive disorder
Coronary artery disease
Cervical cancer
Electroconvulsive therapy
Blood type
Insulin resistance
Multiple chemical sensitivity
Drug addiction
Androgen insensitivity syndrome
Vitamin D
Brain tumor
Attention-deficit hyperactivity disorder